AstraZeneca and Lilly to test new cancer drug combination

LONDON, May 29 (Reuters) - AstraZeneca and Eli Lilly are to combine two of their cancer drugs in a new clinical trial against solid tumours in the latest sign that such cocktails may be the way forward in fighting the disease.